DAVID R. EBSWORTH - 26 Feb 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Andrew Fisher, Attorney-in-fact for David R. Ebsworth
Issuer symbol
VRNA
Transactions as of
26 Feb 2025
Net transactions value
+$600,060
Form type
4
Filing time
28 Feb 2025, 16:30:14 UTC
Previous filing
18 Nov 2024
Next filing
29 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Options Exercise $49,600 +64,000 +6.8% $0.7750 1,004,003 26 Feb 2025 Direct F1
transaction VRNA Ordinary Shares Options Exercise $100,760 +200,000 +20% $0.5038 1,204,003 26 Feb 2025 Direct F1
transaction VRNA Ordinary Shares Options Exercise $256,320 +96,000 +8% $2.67 1,300,003 26 Feb 2025 Direct F1
transaction VRNA Ordinary Shares Options Exercise $193,380 +100,000 +7.7% $1.93 1,400,003 26 Feb 2025 Direct F1
transaction VRNA Ordinary Shares Gift $0 -64,000 -4.6% $0.000000 1,336,003 26 Feb 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRNA Share Option (Right to Exercise) Options Exercise $0 -64,000 -100% $0.000000 0 26 Feb 2025 Ordinary Shares 64,000 $0.7750 Direct F3, F4
transaction VRNA Share Option (Right to Exercise) Options Exercise $0 -200,000 -100% $0.000000 0 26 Feb 2025 Ordinary Shares 200,000 $0.5038 Direct F3, F4
transaction VRNA Share Option (Right to Exercise) Options Exercise $0 -96,000 -100% $0.000000 0 26 Feb 2025 Ordinary Shares 96,000 $2.67 Direct F3, F4
transaction VRNA Share Option (Right to Exercise) Options Exercise $0 -100,000 -42% $0.000000 140,000 26 Feb 2025 Ordinary Shares 100,000 $1.93 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Consists of (i) 1,336,000 Ordinary Shares represented by 167,000 ADSs and (ii) 3 Ordinary Shares.
F3 The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F4 The option is fully vested.
F5 The option vests and becomes exercisable as to 25% on each of July 29, 2024, October 29, 2024, January 29, 2025 and April 29, 2025.